ID   TE 161.T
AC   CVCL_1744
SY   TE-161-T
DR   CLO; CLO_0009293
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-7753
DR   BioSample; SAMN03471146
DR   Cosmic; 909765
DR   IARC_TP53; 27706
DR   Wikidata; Q54971954
RX   PubMed=20164919;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: ATCC; CRL-7753; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 8,11
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//